A drug utilisation post-authorisation study of new users of aclidinium bromide (monotherapy or in combination)

Trial Identifier:	D6560R00005
Sponsor:	AstraZeneca
Collaborator:	RTI Health Solutions
NCTID::	NCT03333018
Start Date:	July 2015
Primary Completion Date:	February 2017
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Denmark	Odense, Denmark
Germany	Bremen, Germany
United Kingdom	London, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.